Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Diabetologia
Published in: Diabetologia 9/2010

01-09-2010 | Editorial

The big fat bariatric bandwagon

Authors: J. H. Pinkney, A. B. Johnson, E. A. M. Gale

Published in: Diabetologia | Issue 9/2010

Login to get access

Excerpt

Dreamworlds say a lot about those who devise them.
Herman Pleij
…
Literature
1.
Pleij H (2001) Dreaming of Cockaigne. Medieval fantasies of the perfect life. Columbia University Press, New York
2.
3.
Sobal J, Stunkard AJ (1989) Socioeconomic status and obesity: a review of the literature. Psychol Bull 105:260–275CrossRefPubMed
4.
Stunkard AJ, Wadden TA (1992) Psychological aspects of severe obesity. Am J Clin Nutr 55:524S–532SPubMed
5.
Connolly HM, Crary JL, McGoon MD et al (1997) Valvular heart disease associated with fenfluramine–phentermine. N Engl J Med 337:581–588CrossRefPubMed
6.
Polak J, Oakley CM, Yacoub M, Mikhail G, Taylor-Robinson SD (1998) Primary pulmonary hypertension: pathologist as patient. J R Coll Physicians Lond 32:225–230PubMed
7.
MacDonald KG Jr (2003) Overview of the epidemiology of obesity and the early history of procedures to remedy morbid obesity. Arch Surg 138:357–360CrossRefPubMed
8.
Mason EE, Ito C (1967) Gastric bypass in obesity. Surg Clin North Am 47:1345–1351PubMed
9.
Karlsson J, Taft C, Ryden A, Sjostrom L, Sullivan M (2007) Ten-year trends in health-related quality of life after surgical and conventional treatment for severe obesity: the SOS Intervention Study. Int J Obes (Lond) 31:1248–1261CrossRef
10.
Gleysteen JJ, Barboriak JJ, Sasse EA (1990) Sustained coronary-risk-factor reduction after gastric bypass for morbid obesity. Am J Clin Nutr 51:774–778PubMed
11.
Sjostrom L, Lindroos AK, Peltonen M et al (2004) Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 351:2683–2693CrossRefPubMed
12.
Sjostrom L, Narbro K, Sjostrom CD et al (2007) Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 357:741–752CrossRefPubMed
13.
Mattar SG, Velcu LM, Rabinovitz M et al (2005) Surgically-induced weight loss significantly improves nonalcoholic fatty liver disease and the metabolic syndrome. Ann Surg 242:610–617, discussion 618–620PubMed
14.
Hooper MM, Stellato TA, Hallowell PT, Seitz BA, Moskowitz RW (2007) Musculoskeletal findings in obese subjects before and after weight loss following bariatric surgery. Int J Obes (Lond) 31:114–120CrossRef
15.
Sugerman HJ, Felton WL 3rd, Salvant JB Jr, Sismanis A, Kellum JM (1995) Effects of surgically induced weight loss on idiopathic intracranial hypertension in morbid obesity. Neurology 45:1655–1659PubMed
16.
Haines KL, Nelson LG, Gonzalez R et al (2007) Objective evidence that bariatric surgery improves obesity-related obstructive sleep apnea. Surgery 141:354–358CrossRefPubMed
17.
Eid GM, Cottam DR, Velcu LM et al (2005) Effective treatment of polycystic ovarian syndrome with Roux-en-Y gastric bypass. Surg Obes Relat Dis 1:77–80CrossRefPubMed
18.
Salem L, Devlin A, Sullivan SD, Flum DR (2008) Cost-effectiveness analysis of laparoscopic gastric bypass, adjustable gastric banding, and nonoperative weight loss interventions. Surg Obes Relat Dis 4:26–32CrossRefPubMed
19.
Keating CL, Dixon JB, Moodie ML et al (2009) Cost-effectiveness of surgically induced weight loss for the management of type 2 diabetes: modeled lifetime analysis. Diab Care 32:567–574CrossRef
20.
Keating CL, Dixon JB, Moodie ML, Peeters A, Playfair J, O’Brien PE (2009) Cost-efficacy of surgically induced weight loss for the management of type 2 diabetes: a randomized controlled trial. Diab Care 32:580–584CrossRef
21.
22.
Libeton M, Dixon JB, Laurie C, O’Brien PE (2004) Patient motivation for bariatric surgery: characteristics and impact on outcomes. Obes Surg 14:392–398CrossRefPubMed
23.
Munoz DJ, Lal M, Chen EY et al (2007) Why patients seek bariatric surgery: a qualitative and quantitative analysis of patient motivation. Obes Surg 17:1487–1491CrossRefPubMed
24.
American Diabetes Association (2010) Standards of medical care in diabetes—2010. Diab Care 33:S11
25.
National Institute for Health and Clinical Excellence (2006) Clinical guideline 43. Obesity. Guidance on the prevention, identification, assessment and management of overweight and obesity in adults and children. National Institute for Health and Clinical Excellence, London
26.
Rubino F, Kaplan LM, Schauer PR, Cummings DE (2010) The Diabetes Surgery Summit consensus conference: recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes mellitus. Ann Surg 251:399–405CrossRefPubMed
27.
West KM (1978) Epidemiology of diabetes and its vascular lesions. Elsevier, New York
28.
Trowell H (1974) Diabetes mellitus death rates in England and Wales 1920–70 and food supplies. Lancet 2:998–1002CrossRefPubMed
29.
Westlund K (1966) Incidence of diabetes mellitus in Oslo, Norway, 1925 to 1954. Br J Prev Soc Med 20:105–116
30.
Buchwald H, Estok R, Fahrbach K et al (2009) Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 122:248–256, e245CrossRefPubMed
31.
Chipkin SR, Goldberg RJ (2009) Obesity surgery and diabetes: does a chance to cut mean a chance to cure? Am J Med 122:205–206CrossRefPubMed
32.
Dixon JB, O’Brien PE, Playfair J et al (2008) Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA 299:316–323CrossRefPubMed
33.
Dixon JB, O’Brien PE (2002) Health outcomes of severely obese type 2 diabetic subjects 1 year after laparoscopic adjustable gastric banding. Diab Care 25:358–363CrossRef
34.
Thaler JP, Cummings DE (2009) Hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery. Endocrinology 150:2518–2525CrossRefPubMed
35.
Chapman AE, Kiroff G, Game P et al (2004) Laparoscopic adjustable gastric banding in the treatment of obesity: a systematic literature review. Surgery 135:326–351CrossRefPubMed
36.
Parikh M, Ayoung-Chee P, Romanos E et al (2007) Comparison of rates of resolution of diabetes mellitus after gastric banding, gastric bypass, and biliopancreatic diversion. J Am Coll Surg 205:631–635CrossRefPubMed
37.
Zalesin K (2009) P-18: differential loss of fat and lean mass in the morbidly obese after bariatric surgery. Surg Obes Relat Dis 5(Suppl):S29–S30CrossRef
38.
Geloneze B, Geloneze SR, Fiori C et al (2009) Surgery for nonobese type 2 diabetic patients: an interventional study with duodenal–jejunal exclusion. Obes Surg 19:1077–1083CrossRefPubMed
39.
Schauer PR, Burguera B, Ikramuddin S et al (2003) Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg 238:467–484, discussion 484–465PubMed
40.
Chikunguwo SM, Wolfe LG, Dodson P et al (2010) Analysis of factors associated with durable remission of diabetes after Roux-en-Y gastric bypass. Surg Obes Relat Dis 6:254–259CrossRefPubMed
41.
UK Prospective Diabetes Study Group (1998) Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 317:703–713
42.
Collins R, Armitage J, Parish S, Sleigh P, Peto R (2003) MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 361:2005–2016CrossRefPubMed
43.
Buchwald H, Estok R, Fahrbach K, Banel D, Sledge I (2007) Trends in mortality in bariatric surgery: a systematic review and meta-analysis. Surgery 142:621–632, discussion 632–625CrossRefPubMed
44.
Morino M, Toppino M, Forestieri P, Angrisani L, Allaix ME, Scopinaro N (2007) Mortality after bariatric surgery: analysis of 13,871 morbidly obese patients from a national registry. Ann Surg 246:1002–1007, discussion 1007–1009CrossRefPubMed
45.
Flum DR, Belle SH, King WC et al (2009) Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med 361:445–454CrossRefPubMed
46.
Omalu BI, Ives DG, Buhari AM et al (2007) Death rates and causes of death after bariatric surgery for Pennsylvania residents, 1995 to 2004. Arch Surg 142:923–928, discussion 929CrossRefPubMed
47.
Varela JE, Wilson SE, Nguyen NT (2006) Outcomes of bariatric surgery in the elderly. Am Surg 72:865–869PubMed
48.
Kellogg TA, Swan T, Leslie DA, Buchwald H, Ikramuddin S (2009) Patterns of readmission and reoperation within 90 days after Roux-en-Y gastric bypass. Surg Obes Relat Dis 5:416–423CrossRefPubMed
49.
Hallowell PT, Stellato TA, Yao DA, Robinson A, Schuster MM, Graf KN (2009) Should bariatric revisional surgery be avoided secondary to increased morbidity and mortality? Am J Surg 197:391–396CrossRefPubMed
50.
Pories WJ, Swanson MS, MacDonald KG et al (1995) Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 222:339–350, discussion 350–352CrossRefPubMed
51.
Shah M, Simha V, Garg A (2006) Review: long-term impact of bariatric surgery on body weight, comorbidities, and nutritional status. J Clin Endocrinol Metab 91:4223–4231CrossRefPubMed
52.
Clements RH, Katasani VG, Palepu R et al (2006) Incidence of vitamin deficiency after laparoscopic Roux-en-Y gastric bypass in a university hospital setting. Am Surg 72:1196–1202, discussion 1203–1204PubMed
53.
Mechanick JI, Kushner RF, Sugerman HJ et al (2008) American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery Medical guidelines for clinical practice for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient. Endocr Pract 14(Suppl 1):1–83PubMed
54.
Fleischer J, Stein EM, Bessler M et al (2008) The decline in hip bone density after gastric bypass surgery is associated with extent of weight loss. J Clin Endocrinol Metab 93:3735–3740CrossRefPubMed
55.
Aasheim ET (2008) Wernicke encephalopathy after bariatric surgery: a systematic review. Ann Surg 248:714–720PubMed
56.
Padwal R, Brocks D, Sharma AM (2010) A systematic review of drug absorption following bariatric surgery and its theoretical implications. Obes Rev 11:41–50CrossRefPubMed
57.
Guelinckx I, Devlieger R, Vansant G (2009) Reproductive outcome after bariatric surgery: a critical review. Hum Reprod Update 15:189–201CrossRefPubMed
58.
Eerdekens A, Debeer A, Van Hoey G et al (2010) Maternal bariatric surgery: adverse outcomes in neonates. Eur J Pediatr 169:191–196CrossRefPubMed
59.
Marsk R, Jonas E, Rasmussen F, Naslund E (2010) Nationwide cohort study of post-gastric bypass hypoglycaemia including 5,040 patients undergoing surgery for obesity in 1986–2006 in Sweden. Diabetologia. doi:10.​1007/​s00125-010-1798-5
60.
Goldfine AB, Mun EC, Devine E et al (2007) Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal. J Clin Endocrinol Metab 92:4678–4685CrossRefPubMed
61.
Kruseman M, Leimgruber A, Zumbach F, Golay A (2010) Dietary, weight, and psychological changes among patients with obesity, 8 years after gastric bypass. J Am Diet Assoc 110:527–534CrossRefPubMed
62.
Adams TD, Gress RE, Smith SC et al (2007) Long-term mortality after gastric bypass surgery. N Engl J Med 357:753–761CrossRefPubMed
63.
Martin LF (2004) Obesity surgery. McGraw-Hill, New York
Metadata
Title
The big fat bariatric bandwagon
Authors
J. H. Pinkney
A. B. Johnson
E. A. M. Gale
Publication date
01-09-2010
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 9/2010
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-010-1845-2

Other articles of this Issue 9/2010

Diabetologia 9/2010 Go to the issue

Erratum

Erratum to: Consensus guidelines, algorithms and care of the individual patient with type 2 diabetes

Commentary

Prime time for DIAMAP: a road map for diabetes research in Europe

Article

Increased levels of peroxisome proliferator-activated receptor gamma, coactivator 1 alpha (PGC-1α) improve lipid utilisation, insulin signalling and glucose transport in skeletal muscle of lean and insulin-resistant obese Zucker rats

Article

Homeostasis model assessment of insulin resistance and the risk of cardiovascular events in middle-aged non-diabetic Japanese men

Short Communication

DDOST, PRKCSH and LGALS3, which encode AGE-receptors 1, 2 and 3, respectively, are not associated with diabetic nephropathy in type 1 diabetes

Letter

Wingless-type MMTV integration site family (WNT) signalling in pancreatic beta cells—more complex than expected
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits